I don’t have any special insight, but in my part of the world that’s definitely a common perception of the USA, usually attributed to lax regulation around what kind of pharmaceutical advertising os permitted.
https://www.cdc.gov/nchs/fastats/drug-use-therapeutic.htm
https://ec.europa.eu/eurostat/statistics-explained/index.php...
they don't seem ahead.
The data sources are not 100% comparable so make of that what you will.